This June, the MINDS team traveled to Denver to share our mission with the broader psychedelic science community. From intimate gatherings with key funders to a presentation on the Doblin stage, the week marked a meaningful step forward in our mission to explore the science of breakthrough insights and human potential.
A Landmark Moment in Denver
At Psychedelic Science 2025, MINDS made its public debut—introducing our research vision to a global audience. We were honored to present our approach to catalyzing creativity and problem-solving through consciousness research to the Psychedelic Science Funders Collaborative, where our work was met with encouragement and enthusiasm.
One of the most moving moments came when Jim Fadiman, co-author of the foundational 1966 study on psychedelics and creativity, joined us by phone during our on-stage session. His blessing felt like a symbolic passing of the torch, connecting nearly six decades of research and affirming our mission to bring creativity science out of the shadows and into the scientific mainstream.
Where Ancient Wisdom Meets Modern Neuroscience
We also hosted an evening event at one of Denver’s first licensed psilocybin centers, where Greek researchers from Athens presented their reconstruction of kykeon, the psychoactive brew used in ancient Greek rituals. Alongside them, neuroscientists shared cutting-edge studies on DMT and consciousness, creating a powerful exchange between ancient traditions and modern inquiry.
This interdisciplinary gathering exemplified the spirit of MINDS—where diverse perspectives come together to advance our understanding of insight, creativity, and human transformation.
